
J Neuropsychiatry Clin Neurosci 14:262-269, August 2002
© 2002 American Psychiatric Press, Inc.
Subcortical Hyperintensities in Alzheimer's Disease
Associated Clinical and Metabolic Findings
David L. Sultzer, M.D.,
Stephen T. Chen, M.D.,
Charles V. Brown, M.D.,
Michael E. Mahler, M.D.,
Jeffrey L. Cummings, M.D.,
Charles H. Hinkin, Ph.D. and
Mark A. Mandelkern, M.D., Ph.D.
Received August 21, 2001; revised January 15, 2002; accepted January 25, 2002. From the Departments of Psychiatry and Biobehavioral Sciences (S.T.C., J.L.C., C.H.H., D.L.S.) and Neurology (J.L.C., M.E.M.), University of California-Los Angeles; and Psychiatry (S.T.C., M.E.M., D.L.S.), Psychology (C.H.H.), and Nuclear Medicine Services (C.V.B., M.A.M.), Veterans Affairs Greater Los Angeles Healthcare System. The views expressed are those of the authors and do not necessarily represent those of the Department of Veterans Affairs. Address correspondence to Dr. Sultzer, Psychiatry, 3South, 116AF, West Los Angeles VA Healthcare Center, 11301 Wilshire Blvd., Los Angeles, CA 90073. E-mail: dsultzer{at}ucla.edu
The authors measured subcortical hyperintensities (SH) on magnetic resonance images (MRI) in 18 patients with probable Alzheimer's disease and examined the relationships of SH severity with cortical metabolic function and clinical symptoms. Severity of SH was not correlated with absolute metabolic rates in cortical lobes. However, anterior SH severity was inversely correlated with frontal/ parietal metabolic ratios after covarying for cognitive impairment. SH severity in some areas was associated with the severity of global neuropsychiatric symptoms, but marked effects on individual symptoms were not apparent. The small sample size and multiple variables limit conclusions that can be drawn. These preliminary findings indicate that subcortical MRI hyperintensities may play a role in the pathophysiology and clinical expression of Alzheimer's disease.
Key Words: Subcortical Hyperintensities Alzheimer's Disease Neuroimaging
This article has been cited by other articles:

|
 |

|
 |
 
B. Kuczynski, B. Reed, D. Mungas, M. Weiner, H. C. Chui, and W. Jagust
Cognitive and Anatomic Contributions of Metabolic Decline in Alzheimer Disease and Cerebrovascular Disease
Arch Neurol,
May 1, 2008;
65(5):
650 - 655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Levy-Cooperman, J. Ramirez, N. J. Lobaugh, and S. E. Black
Misclassified Tissue Volumes in Alzheimer Disease Patients With White Matter Hyperintensities: Importance of Lesion Segmentation Procedures for Volumetric Analysis
Stroke,
April 1, 2008;
39(4):
1134 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Sultzer, C. V. Brown, M. A. Mandelkern, M. E. Mahler, M. F. Mendez, S. T. Chen, and J. L. Cummings
Delusional Thoughts and Regional Frontal/Temporal Cortex Metabolism in Alzheimer's Disease
Am J Psychiatry,
February 1, 2003;
160(2):
341 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2002
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|